Share-based Payment Arrangement, Noncash Expense of Pharma-Bio Serv, Inc. from 31 Jul 2010 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount of noncash expense for share-based payment arrangement.
Summary
Pharma-Bio Serv, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Jul 2010 to 31 Jan 2026.
  • Pharma-Bio Serv, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Jan 2026 was $8,619, a 19% decline year-over-year.
  • Pharma-Bio Serv, Inc. Share-based Payment Arrangement, Noncash Expense for the twelve months ending 31 Jan 2026 was $33,017, a 24% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2025 was $35,079, a 26% decline from 2024.
  • Pharma-Bio Serv, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $47,546, a 5.5% increase from 2023.
  • Pharma-Bio Serv, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $45,084, a 37% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)

Pharma-Bio Serv, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $33,017 $8,619 -$2,062 -19% 01 Nov 2025 31 Jan 2026 10-Q 17 Mar 2026 2026 Q1
Q3 2025 $35,079 $4,399 +$1,253 +40% 01 Aug 2025 31 Oct 2025 10-K 29 Jan 2026 2025 FY
Q2 2025 $33,826 $9,999 -$4,801 -32% 01 May 2025 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $38,627 $10,000 -$4,800 -32% 01 Feb 2025 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $43,427 $10,681 -$4,119 -28% 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2026 2026 Q1
Q3 2024 $47,546 $3,146 +$2,462 +360% 01 Aug 2024 31 Oct 2024 10-K 29 Jan 2026 2025 FY
Q2 2024 $45,084 $14,800 +$1 +0.01% 01 May 2024 31 Jul 2024 10-Q 15 Sep 2025 2025 Q3
Q1 2024 $45,083 $14,800 $0 0% 01 Feb 2024 30 Apr 2024 10-Q 16 Jun 2025 2025 Q2
Q4 2023 $45,083 $14,800 -$1 -0.01% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q1
Q3 2023 $45,084 $684 -$27,761 -98% 01 Aug 2023 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $72,845 $14,799 +$400 +2.8% 01 May 2023 31 Jul 2023 10-Q 16 Sep 2024 2024 Q3
Q1 2023 $72,445 $14,800 +$399 +2.8% 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q2
Q4 2022 $72,046 $14,801 +$401 +2.8% 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024 2024 Q1
Q3 2022 $71,645 $28,445 +$6,496 +30% 01 Aug 2022 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $65,149 $14,399 +$2,969 +26% 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2023 Q3
Q1 2022 $62,180 $14,401 +$2,971 +26% 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023 2023 Q2
Q4 2021 $59,209 $14,400 +$2,970 +26% 01 Nov 2021 31 Jan 2022 10-Q 17 Mar 2023 2023 Q1
Q3 2021 $56,239 $21,949 +$13,361 +156% 01 Aug 2021 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $42,878 $11,430 $0 0% 01 May 2021 31 Jul 2021 10-Q 14 Sep 2022 2022 Q3
Q1 2021 $42,878 $11,430 $0 0% 01 Feb 2021 30 Apr 2021 10-Q 14 Jun 2022 2022 Q2
Q4 2020 $42,878 $11,430 $0 0% 01 Nov 2020 31 Jan 2021 10-Q 17 Mar 2022 2022 Q1
Q3 2020 $42,878 $8,588 +$1,468 +21% 01 Aug 2020 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $41,410 $11,430 +$2,430 +27% 01 May 2020 31 Jul 2020 10-Q 14 Sep 2021 2021 Q3
Q1 2020 $38,980 $11,430 +$2,430 +27% 01 Feb 2020 30 Apr 2020 10-Q 14 Jun 2021 2021 Q2
Q4 2019 $36,550 $11,430 +$2,430 +27% 01 Nov 2019 31 Jan 2020 10-Q 14 Jun 2021 2021 Q2
Q3 2019 $34,120 $7,120 +$8,128 01 Aug 2019 31 Oct 2019 10-K 01 Feb 2021 2020 FY
Q2 2019 $25,992 $9,000 -$8,550 -49% 01 May 2019 31 Jul 2019 10-Q 14 Sep 2020 2020 Q3
Q1 2019 $34,542 $9,000 -$8,550 -49% 01 Feb 2019 30 Apr 2019 10-Q 14 Sep 2020 2020 Q3
Q4 2018 $43,092 $9,000 -$8,550 -49% 01 Nov 2018 31 Jan 2019 10-Q 14 Sep 2020 2020 Q3
Q3 2018 $51,642 $1,008 -$1,008 01 Aug 2018 31 Oct 2018 10-K 29 Jan 2020 2019 FY
Q2 2018 $52,650 $17,550 -$2,225 -11% 01 May 2018 31 Jul 2018 10-Q 16 Sep 2019 2019 Q3
Q1 2018 $54,875 $17,550 -$4,500 -20% 01 Feb 2018 30 Apr 2018 10-Q 16 Sep 2019 2019 Q3
Q4 2017 $59,375 $17,550 -$4,500 -20% 01 Nov 2017 31 Jan 2018 10-Q 16 Sep 2019 2019 Q3
Q3 2017 $63,875 $0 -$22,734 -100% 01 Aug 2017 31 Oct 2017 10-K 29 Jan 2019 2018 FY
Q2 2017 $86,609 $19,775 -$2,275 -10% 01 May 2017 31 Jul 2017 10-Q 14 Sep 2018 2018 Q3
Q1 2017 $88,884 $22,050 $0 0% 01 Feb 2017 30 Apr 2017 10-Q 14 Jun 2018 2018 Q2
Q4 2016 $88,884 $22,050 $0 0% 01 Nov 2016 31 Jan 2017 10-Q 19 Mar 2018 2018 Q1
Q3 2016 $88,884 $22,734 +$43,063 01 Aug 2016 31 Oct 2016 10-K 29 Jan 2018 2017 FY
Q2 2016 $45,821 $22,050 +$1,050 +5% 01 May 2016 31 Jul 2016 10-Q 14 Sep 2017 2017 Q3
Q1 2016 $44,771 $22,050 -$43,398 -66% 01 Feb 2016 30 Apr 2016 10-Q 14 Jun 2017 2017 Q2
Q4 2015 $88,169 $22,050 +$1,050 +5% 01 Nov 2015 31 Jan 2016 10-Q 17 Mar 2017 2017 Q1
Q3 2015 $87,119 $20,329 -$63,429 -147% 01 Aug 2015 31 Oct 2015 10-K 31 Jan 2017 2016 FY
Q2 2015 $150,548 $21,000 +$3,900 +23% 01 May 2015 31 Jul 2015 10-Q 14 Sep 2016 2016 Q3
Q1 2015 $146,648 $65,448 +$48,348 +283% 01 Feb 2015 30 Apr 2015 10-Q 14 Jun 2016 2016 Q2
Q4 2014 $98,300 $21,000 +$3,900 +23% 01 Nov 2014 31 Jan 2015 10-Q 16 Mar 2016 2016 Q1
Q3 2014 $94,400 $43,100 -$3,563 -7.6% 01 Aug 2014 31 Oct 2014 10-K 29 Jan 2016 2015 FY
Q2 2014 $97,963 $17,100 +$14,934 +689% 01 May 2014 31 Jul 2014 10-Q 14 Sep 2015 2015 Q3
Q1 2014 $83,029 $17,100 +$14,934 +689% 01 Feb 2014 30 Apr 2014 10-Q 15 Jun 2015 2015 Q2
Q4 2013 $68,095 $17,100 +$14,934 +689% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q1
Q3 2013 $53,161 $46,663 +$44,497 +2054% 01 Aug 2013 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 $8,664 $2,166 $0 0% 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2014 Q3
Q1 2013 $8,664 $2,166 -$15,000 -87% 01 Feb 2013 30 Apr 2013 10-Q 16 Jun 2014 2014 Q2
Q4 2012 $23,664 $2,166 $0 0% 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q1
Q3 2012 $23,664 $2,166 $0 0% 01 Aug 2012 31 Oct 2012 10-K 29 Jan 2014 2013 FY
Q2 2012 $23,664 $2,166 $0 0% 01 May 2012 31 Jul 2012 10-Q 16 Sep 2013 2013 Q3
Q1 2012 $23,664 $17,166 +$15,000 +693% 01 Feb 2012 30 Apr 2012 10-Q 14 Jun 2013 2013 Q2
Q4 2011 $8,664 $2,166 $0 0% 01 Nov 2011 31 Jan 2012 10-Q 18 Mar 2013 2013 Q1
Q3 2011 $8,664 $2,166 01 Aug 2011 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 $2,166 -$2,664 -55% 01 May 2011 31 Jul 2011 10-Q 14 Sep 2012 2012 Q3
Q1 2011 $2,166 01 Feb 2011 30 Apr 2011 10-Q 14 Jun 2012 2012 Q2
Q4 2010 $2,166 01 Nov 2010 31 Jan 2011 10-Q 16 Mar 2012 2012 Q1
Q2 2010 $4,830 01 May 2010 31 Jul 2010 10-Q 14 Sep 2011 2011 Q3

Pharma-Bio Serv, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $35,079 -$12,467 -26% 01 Nov 2024 31 Oct 2025 10-K 29 Jan 2026 2025 FY
2024 $47,546 +$2,462 +5.5% 01 Nov 2023 31 Oct 2024 10-K 29 Jan 2026 2025 FY
2023 $45,084 -$26,561 -37% 01 Nov 2022 31 Oct 2023 10-K 29 Jan 2025 2024 FY
2022 $71,645 +$15,406 +27% 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2021 $56,239 +$13,361 +31% 01 Nov 2020 31 Oct 2021 10-K 30 Jan 2023 2022 FY
2020 $42,878 +$8,758 +26% 01 Nov 2019 31 Oct 2020 10-K 11 Feb 2022 2021 FY
2019 $34,120 -$17,522 -34% 01 Nov 2018 31 Oct 2019 10-K 01 Feb 2021 2020 FY
2018 $51,642 -$12,233 -19% 01 Nov 2017 31 Oct 2018 10-K 29 Jan 2020 2019 FY
2017 $63,875 -$25,009 -28% 01 Nov 2016 31 Oct 2017 10-K 29 Jan 2019 2018 FY
2016 $88,884 +$1,765 +2% 01 Nov 2015 31 Oct 2016 10-K 29 Jan 2018 2017 FY
2015 $87,119 -$7,281 -7.7% 01 Nov 2014 31 Oct 2015 10-K 31 Jan 2017 2016 FY
2014 $94,400 +$41,239 +78% 01 Nov 2013 31 Oct 2014 10-K 29 Jan 2016 2015 FY
2013 $53,161 +$29,497 +125% 01 Nov 2012 31 Oct 2013 10-K 29 Jan 2015 2014 FY
2012 $23,664 +$15,000 +173% 01 Nov 2011 31 Oct 2012 10-K 29 Jan 2014 2013 FY
2011 $8,664 -$34,714 -80% 01 Nov 2010 31 Oct 2011 10-K 29 Jan 2013 2012 FY
2010 $43,378 01 Nov 2009 31 Oct 2010 10-K/A 31 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.